Ignite Creation Date:
2024-05-05 @ 4:36 PM
Last Modification Date:
2024-10-26 @ 9:22 AM
Study NCT ID:
NCT00272038
Status:
COMPLETED
Last Update Posted:
2018-06-27
First Post:
2006-01-03
Brief Title:
Single Agent Erlotinib in Chemotherapy-naive Androgen Independent Prostate Cancer
Sponsor:
Oncology Specialists SC
Organization:
Oncology Specialists SC
Organization Data
Organization:
Oncology Specialists SC
Class:
OTHER
Study ID:
OSI3652S 0513
Study Type:
None
Study Domain:
None
Study Link:
None
Lead Sponsor:
Oncology Specialists SC
Lead Sponsor Class:
OTHER
Responsible Party:
Dr Sigrun Hallmeyer
Responsible Party Title:
Sigrun Hallmeyer MD Director of Research Chadi Nabhan MD Principal Investigator
Responsible Party Type:
PRINCIPAL_INVESTIGATOR
Responsible Party Affiliation:
Oncology Specialists SC
Old Name:
None
Old Organization:
None